A metabolic synthetic lethal strategy with arginine deprivation and chloroquine leads to cell death in ASS1-deficient sarcomas
2016 · Cell Death and Disease · 99 citations
https://doi.org/10.1038/cddis.2016.232
J
Jeff C. Kremer
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
69
Papers
458
Citations
6
h-index
5
i10-index
Jeff C. Kremer is an academic researcher. The author has contributed to research in topics: Peptidase Inhibition and Analysis & Protein Degradation and Inhibitors & Cancer Research and Treatments. The author has an h-index of 6, co-authored 59 publications.
ORCID: 0009-0003-1841-640XPapers by this author
worksSupplementary Fig. 6 from Discovery and targeting of a noncanonical mechanism of sarcoma resistance to ADI-PEG20 mediated by the microenvironment
2024 · 0 citations
https://doi.org/10.1158/1078-0432.27032368
Supplementary Fig. 7 from Discovery and targeting of a noncanonical mechanism of sarcoma resistance to ADI-PEG20 mediated by the microenvironment
2024 · 0 citations
https://doi.org/10.1158/1078-0432.27032365
Supplementary Tables 1-2 from Discovery and targeting of a noncanonical mechanism of sarcoma resistance to ADI-PEG20 mediated by the microenvironment
2024 · 0 citations
https://doi.org/10.1158/1078-0432.27032362
Supplementary Fig. 1 from Discovery and targeting of a noncanonical mechanism of sarcoma resistance to ADI-PEG20 mediated by the microenvironment
2024 · 0 citations
https://doi.org/10.1158/1078-0432.27032383
Supplementary Fig. 5 from Discovery and targeting of a noncanonical mechanism of sarcoma resistance to ADI-PEG20 mediated by the microenvironment
2024 · 0 citations
https://doi.org/10.1158/1078-0432.27032371.v1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat